214 related articles for article (PubMed ID: 30548873)
1. Gender differences in symptoms and functional status in patients with atrial fibrillation undergoing catheter ablation.
Bazemore TC; Bolger LE; Sears SF; Sadaf MI; Gehi AK
Pacing Clin Electrophysiol; 2019 Feb; 42(2):224-229. PubMed ID: 30548873
[TBL] [Abstract][Full Text] [Related]
2. Relationship between quality of life and burden of recurrent atrial fibrillation following ablation: CAPCOST multicentre cohort study.
Essebag V; Azizi Z; Alipour P; Khaykin Y; Leong-Sit P; Sarrazin JF; Sturmer M; Morillo C; Terricabras M; Amit G; Roux JF; Patterson S; Verma A
Europace; 2020 Jul; 22(7):1017-1025. PubMed ID: 32531030
[TBL] [Abstract][Full Text] [Related]
3. Effects of Ablation Versus Drug Therapy on Quality of Life by Sex in Atrial Fibrillation: Results From the CABANA Trial.
Zeitler EP; Li Y; Silverstein AP; Russo AM; Poole JE; Daniels MR; Al-Khalidi HR; Lee KL; Bahnson TD; Anstrom KJ; Packer DL; Mark DB;
J Am Heart Assoc; 2023 Feb; 12(3):e027871. PubMed ID: 36688367
[TBL] [Abstract][Full Text] [Related]
4. Sex-related risks of recurrence of atrial fibrillation after ablation: Insights from the Guangzhou Atrial Fibrillation Ablation Registry.
Deng H; Shantsila A; Guo P; Potpara TS; Zhan X; Fang X; Liao H; Liu Y; Wei W; Fu L; Xue Y; Wu S; Lip GYH
Arch Cardiovasc Dis; 2019 Mar; 112(3):171-179. PubMed ID: 30683618
[TBL] [Abstract][Full Text] [Related]
5. Symptom Under-Recognition of Atrial Fibrillation Patients in Consideration for Catheter Ablation: A Report From the KiCS-AF Registry.
Katsumata Y; Kohsaka S; Ikemura N; Ueda I; Hashimoto K; Yamashita T; Miyama H; Fujisawa T; Kimura T; Tanimoto K; Momiyama Y; Suzuki M; Fukuda K; Takatsuki S
JACC Clin Electrophysiol; 2021 May; 7(5):565-574. PubMed ID: 33358669
[TBL] [Abstract][Full Text] [Related]
6. Gender and age differences in symptoms and health-related quality of life in patients with atrial fibrillation referred for catheter ablation.
Walfridsson U; Steen Hansen P; Charitakis E; Almroth H; Jönsson A; Karlsson LO; Liuba I; Samo Ayou R; Poci D; Holmqvist F; Kongstad O; Walfridsson H
Pacing Clin Electrophysiol; 2019 Nov; 42(11):1431-1439. PubMed ID: 31495941
[TBL] [Abstract][Full Text] [Related]
7. The Ablate and Pace Trial: a prospective study of catheter ablation of the AV conduction system and permanent pacemaker implantation for treatment of atrial fibrillation. APT Investigators.
Kay GN; Ellenbogen KA; Giudici M; Redfield MM; Jenkins LS; Mianulli M; Wilkoff B
J Interv Card Electrophysiol; 1998 Jun; 2(2):121-35. PubMed ID: 9870004
[TBL] [Abstract][Full Text] [Related]
8. Gender Differences in Clinical Outcomes after Catheter Ablation of Atrial Fibrillation.
Kaiser DW; Fan J; Schmitt S; Than CT; Ullal AJ; Piccini JP; Heidenreich PA; Turakhia MP
JACC Clin Electrophysiol; 2016 Nov; 2(6):703-710. PubMed ID: 29623299
[TBL] [Abstract][Full Text] [Related]
9. Assessment of Sex Differences in the Initial Symptom Burden, Applied Treatment Strategy, and Quality of Life in Japanese Patients With Atrial Fibrillation.
Ikemura N; Kohsaka S; Kimura T; Ueda I; Katsumata Y; Nishiyama T; Aizawa Y; Tanimoto K; Momiyama Y; Akaishi M; Mitamura H; Fukuda K; Spertus JA; Takatsuki S
JAMA Netw Open; 2019 Mar; 2(3):e191145. PubMed ID: 30924896
[TBL] [Abstract][Full Text] [Related]
10. Comparison of CHADS2, R2CHADS2, and CHA2DS2-VASc scores for the prediction of rhythm outcomes after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.
Kornej J; Hindricks G; Kosiuk J; Arya A; Sommer P; Husser D; Rolf S; Richter S; Huo Y; Piorkowski C; Bollmann A
Circ Arrhythm Electrophysiol; 2014 Apr; 7(2):281-7. PubMed ID: 24610790
[TBL] [Abstract][Full Text] [Related]
11. CHADS2 and CHA2DS2-VASc scores as predictors of left atrial ablation outcomes for paroxysmal atrial fibrillation.
Letsas KP; Efremidis M; Giannopoulos G; Deftereos S; Lioni L; Korantzopoulos P; Vlachos K; Xydonas S; Kossyvakis C; Sideris A
Europace; 2014 Feb; 16(2):202-7. PubMed ID: 23813452
[TBL] [Abstract][Full Text] [Related]
12. Paroxysmal Atrial Fibrillation in Females: Understanding gender diferences.
Odozynski G; Forno ARJD; Lewandowski A; Nascimento HG; d'Avila A
Arq Bras Cardiol; 2018 May; 110(5):449-454. PubMed ID: 29723328
[TBL] [Abstract][Full Text] [Related]
13. Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.
Kornej J; Hindricks G; Kosiuk J; Arya A; Sommer P; Husser D; Rolf S; Richter S; Piorkowski C; Gaspar T; Lip GY; Bollmann A
Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):868-74. PubMed ID: 24047706
[TBL] [Abstract][Full Text] [Related]
14. [Impacts of radiofrequency ablation on quality of life of atrial fibrillation patients with low CHA2DS2-VASc score].
Bai Y; Liu N; Bai R; Wu JH; Shi XB; Liu XY; Liu XH; Du X; Dong JZ; Ma CS
Zhonghua Nei Ke Za Zhi; 2016 Apr; 55(4):278-82. PubMed ID: 27030615
[TBL] [Abstract][Full Text] [Related]
15. Successful catheter ablation improves exercise tolerance in persistent atrial fibrillation patients, especially those with reduced ventricular contraction, preserved atrial function, or a high CHADS
Katayama H; Shibata A; Doi A; Ishikawa H; Tamura S; Yamaguchi Y; Matsuo M; Yoshiyama T; Tatsumi H; Iwata S; Ehara S; Izumiya Y; Yoshiyama M
J Cardiol; 2020 May; 75(5):529-536. PubMed ID: 31708409
[TBL] [Abstract][Full Text] [Related]
16. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.
Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ
Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809
[TBL] [Abstract][Full Text] [Related]
17. Validation of a new simple scale to measure symptoms in atrial fibrillation: the Canadian Cardiovascular Society Severity in Atrial Fibrillation scale.
Dorian P; Guerra PG; Kerr CR; O'Donnell SS; Crystal E; Gillis AM; Mitchell LB; Roy D; Skanes AC; Rose MS; Wyse DG
Circ Arrhythm Electrophysiol; 2009 Jun; 2(3):218-24. PubMed ID: 19808471
[TBL] [Abstract][Full Text] [Related]
18. Depression, anxiety, and quality of life after catheter ablation in patients with paroxysmal atrial fibrillation.
Sang CH; Chen K; Pang XF; Dong JZ; Du X; Ma H; Liu JH; Ma CS; Sun YX
Clin Cardiol; 2013 Jan; 36(1):40-5. PubMed ID: 22777577
[TBL] [Abstract][Full Text] [Related]
19. Long-term efficacy of catheter ablation as first-line therapy for paroxysmal atrial fibrillation: 5-year outcome in a randomised clinical trial.
Nielsen JC; Johannessen A; Raatikainen P; Hindricks G; Walfridsson H; Pehrson SM; Englund A; Hartikainen J; Mortensen LS; Hansen PS;
Heart; 2017 Mar; 103(5):368-376. PubMed ID: 27566295
[TBL] [Abstract][Full Text] [Related]
20. Repeat Catheter Ablation of Long-standing Persistent Atrial Fibrillation in Patients with a Total Atrial Fibrillation Duration of More Than 2 Years: Effects of the CHA2DS2-VASc Score and Estimated Glomerular Filtration Rate on the Outcomes.
Wang Q; Jiang SL; Liu X; Yang YQ
Intern Med; 2016; 55(18):2537-47. PubMed ID: 27629945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
